fbpx
QQQ
+ 0.00
314.14
+ 0%
DIA
+ 0.00
308.78
+ 0%
SPY
+ 0.00
380.01
+ 0%
TLT
+ 0.00
143.12
+ 0%
GLD
+ 0.00
161.84
+ 0%

Jim Cramer Weighs In On Berkshire Hathaway, Range Resources, Zynerba And More

July 23, 2019 7:41 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Jim Cramer Weighs In On Berkshire Hathaway, Range Resources, Zynerba And More

On Monday's “Mad Money,” Jim Cramer said he remains bearish on Range Resources Corp. (NYSE:RRC) saying natural gas is the weakest part of the petrol chain.

Cramer says although it's speculative, he is bullish on gene sequencing stock Guardant Health Inc (NASDAQ:GH).

He remains bullish on Berkshire Hathaway Inc. Class B (NYSE: BRK-B) and has been recommending the stock since the show began.

Seattle Genetics, Inc. (NASDAQ:SGEN) is a buy, says Cramer.

Cramer says to steer clear of Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) and if you want to play cannabinoids, GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH) is what he would buy.

Related Links:

'Halftime Report' Final Trades From July 16: American Airlines, JetBlue And More

'Fast Money' Traders Talk Retail: Costco, Target And More